Evidence map›Paper›PMID 32280216›Full record

ArticleInternational journal of nanomedicine2020

An Electrochemical Aptasensor Platform Based on Flower-Like Gold Microstructure-Modified Screen-Printed Carbon Electrode for Detection of Serpin A12 as a Type 2 Diabetes Biomarker.

Armin Salek Maghsoudi, Shokoufeh Hassani, Milad Rezaei Akmal, Mohammad Reza Ganjali, Kayvan Mirnia, Parviz Norouzi, Mohammad Abdollahi

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Armin Salek Maghsoudi *Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Shokoufeh Hassani *Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Milad Rezaei AkmalCenter of Excellence in Electrochemistry, Faculty of Chemistry, University of Tehran, Tehran, Iran.
Mohammad Reza GanjaliCenter of Excellence in Electrochemistry, Faculty of Chemistry, University of Tehran, Tehran, Iran.
Kayvan MirniaDepartment of Neonatology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Parviz NorouziCenter of Excellence in Electrochemistry, Faculty of Chemistry, University of Tehran, Tehran, Iran.
Mohammad AbdollahiDepartment of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-0123-1209
Tehran University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn the present study, a highly sensitive and simple electrochemical (EC) aptasensor for the detection of serpin A12 as a novel biomarker of diabetes was developed on a platform where flower-like gold microstructures (FLGMs) are electrodeposited onto a disposable screen-printed carbon electrode. Meanwhile, serpin A12-specific thiolated aptamer was covalently immobilized on the FLGMs.

methodsThe electrochemical activity of a fabricated aptasensor under various conditions were examined by cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). Aptamer concentration, deposition time, self-assembly time, and incubation time were optimized for assay of serpin A12. The differential pulse voltammetry (DPV) was implemented for quantitative detection of serpin A12 in K

resultsThe label-free aptasensor revealed a linear range of serpin A12 concentration (0.039-10 ng/mL), detection limit of 0.020 ng/mL (S/N=3), and 0.031 ng/mL in solution buffer and plasma, respectively.

conclusionThe results indicate that this aptasensor has a high sensitivity, selectivity, stability, and acceptable reproducibility for detection of serpin A12 in diabetic patients.

Indexed as

ElectrodesAnimalsAptamers, NucleotideBiomarkersBiosensing TechniquesCarbonDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Dielectric SpectroscopyElectrochemical TechniquesElectroplatingEquipment DesignGoldLimit of DetectionMaleRats, WistarAptamers, NucleotideBiomarkersCarbonGoldSERPINA12 protein, humanSerpinsdiabetes biomarkerselectrochemical aptasensorflower-like gold microstructureslabel-free detectionscreen-printed carbon electrodeserpin A12

Identifiers

PMID32280216
PMCPMC7127862
OpenAlexW3013946264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.